Admission Date:  [**2151-3-26**]              Discharge Date:   [**2151-4-5**]  Date of Birth:  [**2088-7-16**]             Sex:   F  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 12**] Chief Complaint: shortness of breath  Major Surgical or Invasive Procedure: pericardiocentesis, with placement of pericardial drain  History of Present Illness: This is a 62 year old female with history of resected pancreatic cancer stage IIB on current gemcitabine rx who presents to CCU s/p pericardial drain.
The patient underwent pericardial drain placement with drainage of 450 cc of blood-tinged serous fluid.
ROS: She denied any fever, chills, headache, dizziness, lightheadedness, abdominal pain, vomiting, diarrhea, weakness, tingling, numbness, difficulty speaking/swallowing, or bowel/bladder incontinence.
Past Medical History: PAST MEDICAL HISTORY: Pancreatic cancer s/p whipple in 09 HTN History of TB treated 40 years ago with INH and pyrazinamide R eyelid basal cell skin cancer (R) carpal tunnel syndrome s/p hysterectomy for symptomatic fibroids (menorrhagia and anemia) in [**2138**] carpal tunnel release [**2139**] basal cell skin cancer excision from (R) eyelid [**2142-9-18**] .
She underwent Whipple procedure and open cholecystectomy.
She is status post CyberKnife boost on [**2150-7-9**] followed by radiation with concurrent capecitabine.
Currently, she is undergoing gemcitabine rx, that has been complicated by neutropenia, requiring dose reduction.
Clean dressing in place over right cath site.
Peri-bronchovascular ground-glass opacity may represent pulmonary edema.
At least one subcentimeter nodular opacity which was not previously identified; recommend continued CT followup to exclude recurrence, and if possible IV contrast.
Pericardial effusion: Pt admitted to MICU and pericardial drain placed.
Pericardial fluid with WBC 500 (diff polys 1, lymphs 3, mesothel 11, macro 52, other 33), RBC [**Numeric Identifier 45281**].
Haptoglobin trended up throughout admission.
Pt treated c teds, elevation of LE and lasix 40 mg daily.
Pt was continued on amlodipine and hctz-lisinopril switched to labetolol given [**Last Name (un) **].
Pancreatic cancer: Stage IIB s/p Whipple, radiation, capecitabine and recent gemcitabine course.
# Pulmonary Nodule: new, recommend re-imaging with IV contrast once renal function improves.
Communication: HCP is husband [**Name (NI) **] [**Name (NI) 82631**] ([**Telephone/Fax (1) 82632**] (cell)  Medications on Admission: AMLODIPINE - 10 mg Tablet - 1 Tablet(s) by mouth daily LIPASE-PROTEASE-AMYLASE [CREON] - 120,000 unit-[**Unit Number **],000 unit-[**Unit Number **],000 unit Capsule, Delayed Release (E.C.)
- 1 Tablet(s) by mouth two times a day PAROXETINE HCL - 10 mg Tablet - 1 Tablet(s) by mouth daily CALCIUM CITRATE-VITAMIN D3 [CALCITRATE-VITAMIN D] - 315mg-200 unit Tablet - 2 Tablet(s) by mouth daily CHOLECALCIFEROL (VITAMIN D3) [DELTA D3] - 400 unit Tablet - 1 Tablet(s) by mouth daily MULTIVITAMIN,TX-MINERALS [MULTI-VITAMIN HP/MINERALS] - Capsule - 1 Capsule(s) by mouth daily OMEGA-3 FATTY ACIDS [FISH OIL] - 1,200 mg-144 mg Capsule - 1 Capsule(s) by mouth daily  Discharge Medications: 1.
Amlodipine 10 mg Tablet Sig: One (1) Tablet PO once a day.
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Paxil 10 mg Tablet Sig: One (1) Tablet PO once a day.
Calcitrate-Vitamin D 315-200 mg-unit Tablet Sig: Two (2) Tablet PO once a day.
Labetalol 200 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Furosemide 20 mg Tablet Sig: Two (2) Tablet PO once a day.
ZOFRAN ODT 8 mg Tablet, Rapid Dissolve Sig: One (1) Tablet, Rapid Dissolve PO every eight (8) hours as needed for nausea.
With all of the information that we have we think you probably had a rare side effect of gemcitabine called gemcitabine-induced hemolytic uremic syndrome which causes hemolysis and kidney injury.
Lasix 40 mg daily 4.
Folic Acid 1 mg daily  You can discuss with Dr [**Last Name (STitle) 1852**] and Dr [**Last Name (STitle) **] whether you need additional chemotherapy when you see them next week.
Appointment #2 MD: Dr. [**First Name4 (NamePattern1) 3065**] [**Last Name (NamePattern1) 4762**] Specialty: Hematology Date/ Time: [**2151-4-16**] 3:00pm Location: [**Location (un) 830**] [**Hospital Ward Name 23**] Building [**Location (un) 24**], [**Location (un) 86**] MA Phone number: [**Telephone/Fax (1) 16482**]  Appointment #3: Provider: [**First Name8 (NamePattern2) 251**] [**Name11 (NameIs) **], MD Phone:[**Telephone/Fax (1) 2835**] Date/Time:[**2151-4-12**] 11:30 Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern1) 593**], MD Phone:[**Telephone/Fax (1) 22**] Date/Time:[**2151-4-12**] 1:00  Appointment #4: Nephrology (Kidney Doctor) Physician: [**Last Name (NamePattern4) **].
Please talk to Dr [**Last Name (STitle) 1852**] or Dr [**Last Name (STitle) **] at [**Telephone/Fax (1) 22**] before going to this appointment as they may not want to do it anymore given your kidney function.
